Canada
· Delayed Price · Currency is CAD MustGrow Biologics Statistics
Total Valuation
TSXV:MGRO has a market cap or net worth of CAD 56.29 million. The enterprise value is 53.81 million.
| Market Cap | 56.29M |
| Enterprise Value | 53.81M |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:MGRO has 51.64 million shares outstanding. The number of shares has increased by 3.41% in one year.
| Current Share Class | 51.64M |
| Shares Outstanding | 51.64M |
| Shares Change (YoY) | +3.41% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 12.12% |
| Owned by Institutions (%) | n/a |
| Float | 44.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 141.42 |
| PB Ratio | 25.94 |
| P/TBV Ratio | 35.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.01 |
| EV / Sales | 135.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.61 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -126.10% and return on invested capital (ROIC) is -62.46%.
| Return on Equity (ROE) | -126.10% |
| Return on Assets (ROA) | -45.66% |
| Return on Invested Capital (ROIC) | -62.46% |
| Return on Capital Employed (ROCE) | -179.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.81% in the last 52 weeks. The beta is 2.42, so TSXV:MGRO's price volatility has been higher than the market average.
| Beta (5Y) | 2.42 |
| 52-Week Price Change | +3.81% |
| 50-Day Moving Average | 1.10 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 48.94 |
| Average Volume (20 Days) | 6,943 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:MGRO had revenue of CAD 398,018 and -4.89 million in losses. Loss per share was -0.09.
| Revenue | 398,018 |
| Gross Profit | 80,493 |
| Operating Income | -4.51M |
| Pretax Income | -4.89M |
| Net Income | -4.89M |
| EBITDA | n/a |
| EBIT | -4.51M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 3.00 million in cash and 517,991 in debt, giving a net cash position of 2.48 million or 0.05 per share.
| Cash & Cash Equivalents | 3.00M |
| Total Debt | 517,991 |
| Net Cash | 2.48M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 2.17M |
| Book Value Per Share | 0.04 |
| Working Capital | 1.76M |
Cash Flow
| Operating Cash Flow | -3.58M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 20.22% |
| Operating Margin | -1,133.77% |
| Pretax Margin | -1,228.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:MGRO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.41% |
| Shareholder Yield | -3.41% |
| Earnings Yield | -8.69% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSXV:MGRO has an Altman Z-Score of 1.8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.8 |
| Piotroski F-Score | n/a |